Arcutis Biotherapeutics (ARQT) EBITDA Margin (2022 - 2025)
Arcutis Biotherapeutics (ARQT) posted EBITDA Margin of -32.50% for Q1 2025, up 30.58 percentage points from -63.07% a year earlier but down 22.44 percentage points from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) EBITDA Margin (2022 - 2025) Analysis & Trends
For the trailing twelve months through Mar 31, 2025, EBITDA Margin at Arcutis Biotherapeutics was -54.47%, down 47.81 percentage points year-over-year; for FY2024, it was -64.01%, up 337.89 percentage points from FY2023.
- In prior years, Arcutis Biotherapeutics' EBITDA Margin was -401.89% in FY2023 (+7755.81 pp) and -8157.70% in FY2022.
- Quarterly EBITDA Margin has run from a low of -14409.10% in Q3 2022 to a high of 397.01% in Q3 2023 over five years.
- On a year-over-year basis, EBITDA Margin increased in six of the last seven quarters, with an average year-over-year change of +2918.36 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -10.05% (Q4 2024), -84.09% (Q3 2024) and -161.10% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 39.16% |
| 10 | Arcutis Biotherapeutics | 4.24 Bn | 3.53 Bn | 118.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -32.50% |
| Dec 31, 2024 | -10.05% |
| Sep 30, 2024 | -84.09% |
| Jun 30, 2024 | -161.10% |
| Mar 31, 2024 | -63.07% |
| Dec 31, 2023 | -449.17% |
| Sep 30, 2023 | 397.01% |
| Jun 30, 2023 | -1,278.71% |
| Mar 31, 2023 | -2,729.31% |
| Dec 31, 2022 | -2,299.12% |
| Sep 30, 2022 | -14,298.48% |
API Access
Arcutis Biotherapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();